Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Wiley full text link Wiley Free PMC article
Full text links

Actions

Share

Review
.2020 Aug;97(8):772-776.
doi: 10.1002/cyto.a.24172. Epub 2020 Jul 18.

Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis

Affiliations
Review

Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis

Wei Huang et al. Cytometry A.2020 Aug.

Abstract

A reduced peripheral blood absolute lymphocyte count with an elevated neutrophil count has been a consistent observation in hospitalized coronavirus disease 2019 (COVID-19) patients. In this brief meta-analysis, the reduction of lymphocyte subset counts in COVID-19 patients was investigated across 20 peer-reviewed studies meeting criteria for reporting lymphocyte subset counts and COVID-19 disease severity. CD4+ T cell, CD8+ T cell, B cell, NK cell, and total lymphocyte cell counts all showed statistically significant reduction in patients with severe/critical COVID-19 disease compared to mild/moderate disease. T-cell subsets showed the largest standardized magnitude of change. In some studies, multivariate analysis has shown that CD4 and/or CD8 T-cells counts are independently predictive of patient outcomes. © 2020 International Society for Advancement of Cytometry.

Keywords: COVID-19; T-cell subset; flow cytometry; immunophenotyping; lymphocyte subset.

© 2020 International Society for Advancement of Cytometry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean cell counts for each individual lymphocyte subset in mild/moderate and severe/critical COVID‐19 patients across articles. Each solid circle represents the mean cell count in one article and the size of the circle represents the relative sample size for the mean. Paired data points from the same article are connected. The weighted mean value of cell counts across all articles is also shown with 95% confidence interval (CI) based on the random variability across articles. [Color figure can be viewed atwileyonlinelibrary.com]
Figure 2
Figure 2
Standardized mean differences (SMDs) between mild/moderate and severe/critical disease groups, with 95% confidence interval (95%CI), in COVID‐19 patients. There is one panel for total lymphocytes, as well as panels for each subset. SMDs with CI results on the left of the 0 vertical line indicate a negative difference, i.e., the average mean count in the severe/critical group was significantly lower than in the mild/moderate group. Note that the width of the individual CIs is a function of sample size and reported variability within each publication.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–733. 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia. N Engl J Med 2020;382:1199–1207. 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Cao X. COVID‐19: Immunopathology and its implications for therapy. Nat Rev Immunol 2020;20(5):269–270. - PMC - PubMed
    1. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A meta‐analysis. Clin Chem Lab Med 2020;58(7):1021–1028. 10.1515/cclm-2020-0369. - DOI - PubMed
    1. Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID‐19 ‐ A systematic review. Life Sci 2020;254:117788. 10.1016/j.lfs.2020.117788. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

Full text links
Wiley full text link Wiley Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp